Author:
Galanello Renzo,Piga Antonio,Cappellini Maria Domenica,Forni Gian Luca,Zappu Antonella,Origa Raffaella,Dutreix Catherine,Belleli Rossella,Ford John M.,Rivière Gilles-Jacques,Balez Sébastien,Alberti Daniele,Séchaud Romain
Subject
Pharmacology (medical),Pharmacology
Reference20 articles.
1. Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferroxamine;Aldouri;J Clin Pathol,1987
2. Clinical consequences of acquired transfusional iron overload in adults;Schafer;N Engl J Med.,1981
3. Pulmonary iron overload in thalassemia major presenting as small airway disease;Ooi;Acta Haematol,2002
4. Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload;Piga;Haematologica,2006
5. Practical management of iron overload;Porter;Br J Haematol,2001
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献